These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 8447150)

  • 1. Antipyrine elimination in patients with alcoholic and non-alcoholic cirrhosis.
    Wensing G; Hoffmann K; Heidemann HT
    Z Gastroenterol; 1993 Jan; 31(1):15-9. PubMed ID: 8447150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quinidine disposition in relation to antipyrine elimination and debrisoquine phenotype in alcoholic patients with and without cirrhosis.
    Debruyne D; Gram LF; Grollier G; Camsonne R; Agron L; Dao MT; Lacotte J; Bigot MC; Moulin M
    Int J Clin Pharmacol Res; 1989; 9(5):319-25. PubMed ID: 2625371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison between antipyrine and aminopyrine blood clearances.
    Kawasaki S; Imamura H; Kokudo N; Bandai Y; Sanjo K; Idezuki Y
    Hepatogastroenterology; 1992 Aug; 39(4):344-6. PubMed ID: 1427580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indocyanine green clearance test and model for end-stage liver disease score of patients with liver cirrhosis.
    Sheng QS; Lang R; He Q; Yang YJ; Zhao DF; Chen DZ
    Hepatobiliary Pancreat Dis Int; 2009 Feb; 8(1):46-9. PubMed ID: 19208514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocellular carcinomas do not compromise quantitative tests of liver function.
    Ganslmayer M; Ocker M; Zopf S; Schuppan D; Hahn EG; Herold C
    Hepatogastroenterology; 2005; 52(63):881-4. PubMed ID: 15966225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antipyrine clearance in comparison to conventional liver function tests in hepatitis C virus patients.
    Mahmoud M; Abdel-Kader R; Hassanein M; Saleh S; Botros S
    Eur J Pharmacol; 2007 Aug; 569(3):222-7. PubMed ID: 17628532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caffeine elimination in cirrhotic and non-cirrhotic liver disease of different etiology.
    Joeres R; Brachtel D; Gallenkamp H; Hofstetter G; Klinker H; Zilly W; Richter E
    Z Gastroenterol; 1993 Feb; 31 Suppl 2():56-61. PubMed ID: 7483716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fractional clearance of bromosulfonephthalein and metabolic clearance of antipyrine. Correlative study in liver diseases.
    Couet C; Brissot P; Messner M; Delamaire D; Gie S; Bourel M
    Ann Gastroenterol Hepatol (Paris); 1984; 20(1):1-6. PubMed ID: 6529154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum leptin levels in alcoholic liver cirrhosis: relationship with gender, nutritional status, liver function and energy metabolism.
    Campillo B; Sherman E; Richardet JP; Bories PN
    Eur J Clin Nutr; 2001 Nov; 55(11):980-8. PubMed ID: 11641747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver function and medroxyprogesterone acetate elimination in man.
    Rautio A
    Biomed Pharmacother; 1984; 38(4):199-204. PubMed ID: 6498308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colchicine clearance is impaired in alcoholic cirrhosis.
    Leighton JA; Bay MK; Maldonado AL; Schenker S; Speeg KV
    Hepatology; 1991 Dec; 14(6):1013-5. PubMed ID: 1959847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antipyrine clearance in liver resections].
    Fiorentini MT; Fracchia M; Biondi AM; Capussotti L; De La Pierre M; Molino G
    Minerva Dietol Gastroenterol; 1990; 36(4):209-13. PubMed ID: 2089284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical utility of red cell distribution width in alcoholic and non-alcoholic liver cirrhosis.
    Milić S; Mikolasević I; Radić M; Hauser G; Stimac D
    Coll Antropol; 2011 Sep; 35 Suppl 2():335-8. PubMed ID: 22220466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spironolactone and enzyme induction in patients with alcoholic cirrhosis.
    Miguet JP; Vuitton D; Thebault-Lucas A; Joanne C; Dhumeaux D
    Gastroenterology; 1980 May; 78(5 Pt 1):996-1000. PubMed ID: 7380205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antipyrine clearance and its correlation to routine liver function tests in patients with liver disease.
    Krausz Y; Zylber-Katz E; Levy M
    Int J Clin Pharmacol Ther Toxicol; 1980 Jun; 18(6):253-7. PubMed ID: 7450926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysfunction of the hypothalamic-pituitary-glandular axes and relation to Child-Pugh classification in male patients with alcoholic and virus-related cirrhosis.
    Zietz B; Lock G; Plach B; Drobnik W; Grossmann J; Schölmerich J; Straub RH
    Eur J Gastroenterol Hepatol; 2003 May; 15(5):495-501. PubMed ID: 12702906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antipyrine as a probe for human oxidative drug metabolism: identification of the cytochrome P450 enzymes catalyzing 4-hydroxyantipyrine, 3-hydroxymethylantipyrine, and norantipyrine formation.
    Engel G; Hofmann U; Heidemann H; Cosme J; Eichelbaum M
    Clin Pharmacol Ther; 1996 Jun; 59(6):613-23. PubMed ID: 8681486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antipyrine clearance as a measure of drug metabolism in patients with diabetes mellitus].
    Oltmanns D; Dennin DE; Pentz R; Siegers CP
    Z Gastroenterol; 1984 Oct; 22(10):598-601. PubMed ID: 6506825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of quantitative methods to assess hepatic function: Pugh's classification, indocyanine green, antipyrine, and dextromethorphan.
    Figg WD; Dukes GE; Lesesne HR; Carson SW; Songer SS; Pritchard JF; Hermann DJ; Powell JR; Hak LJ
    Pharmacotherapy; 1995; 15(6):693-700. PubMed ID: 8602375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Quantification of the drug-metabolizing enzyme system in liver diseases: a comparison between antipyrine saliva clearance and the aminopyrine breath test].
    von Mandach U; Jost G; Preisig R
    Schweiz Med Wochenschr; 1985 May; 115(19):651-8. PubMed ID: 3923620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.